Mathematical and Experimental Analyses of Antibody Tran Hollow-Fiber-Based Specific Antibody Filters

Biotechnology Progress

Volumn 19, Issue 5, 2003, Pages 1553-1561

  Hout, Mariah S ^a,b   Federspiel, William J ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BLOOD; DIFFUSION; FIBERS; PATHOLOGY;

SPECIFIC ANTIBODY FILTERS (SAF);

BIOTECHNOLOGY;

ANTIBODIES; ANTIGEN-ANTIBODY COMPLEX; CAPILLARITY; COMPUTER SIMULATION; MEMBRANES, ARTIFICIAL; MICROFLUIDICS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PERMEABILITY; POROSITY; SERUM ALBUMIN, BOVINE; ULTRAFILTRATION;

BOVINAE;

EID: 0141942542     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp025796f     Document Type: Article

References (45)

1. Tanabe, K.; Takahashi, K.; Sonda, K.; Tokumoto, T.; Ishikawa, N.; Kawai, T.; Fuchinoue, S.; Oshima, T.; Yagisawa, T.; Nakazawa, H.; Goya, N.; Koga, S.; Kawaguchi, H.; Ito, K.; Toma, H.; Agishi, T.; Ota, K. Long-Term Results of ABO-Incompatible Living Kidney Transplantation-A Single-Center Experience. Transplantation 1998, 65, 224-228.
2. Cooper, D. K.; Human, P. A.; Lexer, G.; Rose, A. G.; Rees, J.; Keraan, M.; Du Toit, E. Effects of Cyclosporine and Antibody Adsorption on Pig Cardiac Xenograft Survival in the Baboon. J. Heart Transplant. 1988, 7, 238-246.
3. Xu, Y.; Lorf, T.; Sablinski, T.; Gianello, P.; Bailin, M.; Monroy, R.; Kozlowski, T.; Awwad, M.; Cooper, D. K. C.; Sachs, D. H. Removal of Anti-Porcine Natural Antibodies from Human and Nonhuman Primate Plasma in Vitro and in Vivo by a Gal Alpha 1-3gal Beta 1-4 Beta Glc-X Immunoaffmity Column. Transplantation 1998, 65, 172-179.
4. Kluth, D. C.; Rees, A. J. Anti-Glomerular Basement Membrane Disease. J. Am. Soc. Nephrol. 1999, 10, 2446-2453.
5. Benny, W. B.; Sutton, D. M.; Oger, J.; Bril, V.; McAteer, M. J.; Rock, G. Clinical Evaluation of a Staphylococcal Protein A Immunoadsorption System in the Treatment of Myasthenia Gravis Patients. Transfusion 1999, 39, 682-687.
6. Knobl, P.; Derfler, K. Extracorporeal Immunoadsorption for the Treatment of Haemophilic Patients with Inhibitors to Factor VIII or IX. Vox Sang 1999, 77 Suppl 1, 57-64.
7. Snyder, H. W., Jr.; Cochran, S. K.; Balint, J. P., Jr.; Bertram, J. H.; Mittelman, A.; Guthrie, T. H., Jr.; Jones, F. R. Experience with Protein A-Immunoadsorption in Treatment-Resistant Adult Immune Thrombocytopenic Purpura. Blood 1992, 79, 2237-2245.
8. Madore, F. Plasmapheresis. Technical Aspects and Indications. Crit. Care Clin. 2002, 18, 375-392.
9. Matic, G.; Bosch, T.; Ramlow, W. Background and Indications for Protein A-Based Extracorporeal Immunoadsorption. Ther. Apheresis 2001, 5, 394-403.
10. Nydegger, U. E.; Rieben, R.; Mohacsi, P. Current Precision of Immunological Extracorporeal Plasma Treatment. Transfus Apheresis Sci. 2001, 24, 39-47.
11. Braun, N.; Bosch, T. Immunoadsorption, Current Status and Future Developments. Expert Opin. Invest. Drugs 2000, 9, 2017-2038.
12. Bertram, J. H.; Jones, F. R.; Balint, J. P., Jr. Protein A Immunoadsorption. Clin. Immunother. 1996, 6, 211-227.
13. Hout, M. S.; LeJeune, K. E.; Schaack, T. M.; Bristow, D. K.; Federspiel, W. J. Specific Removal of Anti-A and Anti-B Antibodies by Using Modified Dialysis Filters. ASAIO J. 2000, 46, 702-706.
14. Hout, M. S. Selective Antibody Removal from Blood, Plasma, and Buffer Using Hollow Fiber-Based Specific Antibody Filters. Ph.D. Dissertation, University of Pittsburgh, 2003.
15. Singh, P.; Goldman, J.; Jackson, C. E. Preparation and In Vitro Evaluation of a New Extracorporeal Dialyzer with Immobilized Insulin. Artif. Organs 1982, 6, 145-150.
16. Larue, C.; Gueraud, V.; Rivat, C. Suitable Hollow Fibre Immunobioreactors for Specific Ex Vivo Removal of Antibodies and Antigens from Plasma. Clin. Exp. Immunol. 1985, 62, 217-224.
17. Yang, V. C.; Port, F. K.; Kim, J. S.; Teng, C. L.; Till, G. O.; Wakefield, T. W. The Use of Immobilized Protamine in Removing Heparin and Preventing Protamine-Induced Complications During Extracorporeal Blood Circulation. Anesthesiology 1991, 75, 288-297.
18. Ma, X.; Mohammad, S. F.; Kim, S. W. Heparin Removal from Blood Using Poly(L-Lysine) Immobilized Hollow Fiber. Biotechnol. Bioeng. 1992, 40, 530-536.
19. Karoor, S.; Molina, J.; Buchmann, C. R.; Colton, C.; Logan, J. S.; Henderson, L. W. Immunoaffinity Removal of Xenore-active Antibodies Using Modified Dialysis or Microfiltration Membranes. Biotechnol. Bioeng. 2003, 81, 134-148.
20. Klein, E.; Eichholz, E.; Yeager, D. H. Affinity Membranes Prepared from Hydrophilic Coatings on Microporous Polysulfone Hollow Fibers. J. Membr. Sci. 1994, 90, 69-80.
21. Charcosset, C.; Su, Z.; Karoor, S.; Daun, G.; Colton, C. K. Protein A Immunoaffinity Hollow Fiber Membranes for Immunoglobulin G Purification: Experimental Characterization. Biotechnol. Bioeng. 1995, 48, 415-427.
22. Cussler, E. L. Diffusion: Mass Transfer in Fluid Systems, 2nd ed.; Cambridge University Press: Cambridge, New York, 1997.
23. Bamford, C. H.; Al-Lamee, K. G.; Purbrick, M. D.; Wear, T. J. Studies of a Novel Membrane for Affinity Separations. J. Chromatogr. 1992, 606, 19-31.
24. Instructions for Use of Hemodialyzers; Gambro: Lakewood, CO.
25. Yarmush, D. M.; Murphy, R. M.; Colton, C. K.; Fisch, M.; Yarmush, M. L. Quasi-Elastic Light Scattering of Antigen-Antibody Complexes. Mol. Immunol. 1988, 25, 17-32.
26. Kuby, J. Immunology, 3rd ed.; W. H. Freeman: New York, 1997.
27. Yarmush, M. L.; Patankar, D. B.; Yarmush, D. M. An Analysis of Transport Resistances in the Operation of Biacore; Implications for Kinetic Studies of Biospecific Interactions. Mol. Immunol. 1996, 33, 1203-1214.
28. Chase, H. A. Affinity Separations Utilising Immobilised Monoclonal Antibodies - A New Tool for the Biochemical Engineer. Chem. Eng. Sci. 1984, 39, 1099-1125.
29. Peters, T., Jr. Serum Albumin. Adv. Protein. Chem. 1985, 37, 161-245.
30. Welty, J. R.; Wicks, C. E.; Wilson, R. E. Fundamentals of Momentum, Heat, and Mass Transfer, 3rd ed.; Wiley: New York, 1984.
31. Deen, W. M. Analysis of Transport Phenomena; Oxford University Press: New York, 1998.
32. Fournier, R. L. Basic Transport Phenomena in Biomedical Engineering; Taylor & Francis: Philadelphia, 1999.
33. Sargent, J. A.; Gotch, F. A. Principles and Biophysics of Dialysis. In Replacement of Renal Function by Dialysis, 4th ed.; Jacobs, C., Kjellstrand, C. M., Koch, K. M., Winchester, J. P., Eds.; Kluwer Academic Publishers: Dordrecht, 1996.
34. von Sengbusch, G.; Lemke, H. D.; Vienken, J. Evolution of Membrane Technology: Possibilities and Consequences. In Uremia Therapy; Gurland, H. J., Ed.; Springer-Verlag: Berlin, 1987.
35. Colton, C. K.; Lysaght, M. J. Membranes for Hemodialysis. In Replacement of Renal Function by Dialysis, 4th ed.; Jacobs, C., Kjellstrand, C. M., Koch, K. M., Winchester, J. F., Eds.; Kluwer Academic Publishers: Dordrecht, 1996.
36. Axen, R.; Porath, J.; Ernback, S. Chemical Coupling of Peptides and Proteins to Polysaccharides by Means of Cyanogen Halides. Nature 1967, 214, 1302-1304.
37. Crowther, J. R. The ELISA Guidebook; Humana Press: Totowa, NJ, 2001.
38. al-Yaman, F.; Genton, B.; Falk, M.; Anders, R. F.; Lewis, D.; Hii, J.; Beck, H. P.; Alpers, M. P. Humoral Response to Plasmodium Falciparum Ring-Infected Erythrocyte Surface Antigen in a Highly Endemic Area of Papua New Guinea. Am. J. Trop. Med. Hyg. 1995, 52, 66-71.
39. Kozlowski, T.; Ierino, F. L.; Lambrigts, D.; Foley, A.; Andrews, D.; Awwad, M.; Monroy, R.; Cosimi, A. B.; Cooper, D. K.; Sachs, D. H. Depletion of Anti-Gal(Alpha)1-3gal Antibody in Baboons by Specific Alpha-Gal Immunoaffmity Columns. Xenotransplantation 1998, 5, 122-131.
40. Instructions for Imject Carrier Proteins BSA, KLH, and OVA; Pierce Chemical Company: Rockford, IL.
41. Rieben, R.; Korchagina, E. Y.; von Allmen, E.; Hovinga, J. K.; Lammle, B.; Jungi, T. W.; Bovin, N. V.; Nydegger, U. E. In Vitro Evaluation of the Efficacy and Biocompatibility of New, Synthetic ABO Immunoabsorbents. Transplantation 1995, 60, 425-430.
42. Gerber, B.; Tinguely, C.; Bovin, N. V.; Rieben, R.; Nydegger, U. E. Differences between Synthetic Oligosaccharide Immunoabsorbents in Depletion Capacity for Xenoreactive Anti-Galalpha1-3gal Antibodies from Human Serum. Xenotransplantation 2001, 8, 106-114.
43. Roitt, I. M.; Brostoff, J.; Male, D. K. Immunology, 4th ed.; Mosby: London, Baltimore, 1996.
44. Bruining, W. J. A General Description of Flows and Pressures in Hollow Fiber Membrane Modules. Chem. Eng. Sci. 1989, 44, 1441-1447.
45. Wang, N. H. L.; Keller, K. H. Augmented Transport of Extracellular Solutes in Concentrated Erythrocyte Suspensions in Couette Flow. J, Colloid Interface Sci. 1985, 103, 210-225.